Adverse CNS-effects of beta-adrenoceptor blockers

Pharmacopsychiatry
C H Gleiter, J Deckert

Abstract

In 1962 propranolol, the first beta adrenoceptor antagonist (beta blocker), was brought on to the market. There is now a host of different beta blockers available, and these compounds are among the most commonly prescribed groups of drugs. The efficacy of beta blockers has been proven predominantly for the treatment of cardiovascular diseases. Beta blockers are also used for certain types of CNS disorders, such as anxiety disorders, essential tremor and migraine. While low toxicity means that they have a favorable risk-benefit ratio, given the high intensity of use, it is essential to have a comprehensive knowledge of adverse events. Adverse events of beta blockers that can be related to the CNS are quite often neglected, even in textbooks of clinical pharmacology or review articles, and thus often misdiagnosed. The following article, therefore, after summarizing the use of beta blockers for CNS indications, critically reviews the literature on centrally mediated adverse events. General pharmacological features of beta blockers and their molecular basis of action will briefly be addressed to the extent that they are or may become relevant for central nervous pharmacotherapy and side-effects.

Citations

Mar 15, 2005·General Hospital Psychiatry·Robertas BuneviciusArthur J Prange
Apr 20, 2014·Journal of Clinical Psychopharmacology·Yanhong WeiSuowei Wu
Jun 5, 2002·Current Neurology and Neuroscience Reports·Theresa A ZesiewiczRobert A Hauser
Aug 2, 2008·Clinical Neuropharmacology·Jutta Hensel, Frank Pillmann
Apr 14, 1999·Journal of Cardiopulmonary Rehabilitation·D J MoserP L Tilkemeier
Sep 12, 2007·Annual Review of Medicine·Daniel P Judge, Harry C Dietz
Jul 29, 2006·Drugs & Aging·Paola SarchielliPaolo Calabresi
Nov 20, 2009·The International Journal of Neuroscience·Martina Pitzer, Martin H Schmidt
Apr 21, 2012·General Hospital Psychiatry·Ying ZhaoWenli Yang
Mar 1, 2006·The American Journal of Geriatric Pharmacotherapy·Michael KotlyarDavid E Adson
Oct 5, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Zai-Wang LiRong-Hua Tang
Nov 10, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·S LiachenkoY Xu
Feb 28, 2008·Headache·Randolph W EvansDhirendra Bana
Feb 6, 2014·Cardiovascular Therapeutics·Elizabeth A GreenSatish R Raj
Apr 17, 2004·The Medical Clinics of North America·Asher Qureshi, Teofilo Lee-Chiong
Jun 7, 2016·Journal of Pineal Research·Fedor SimkoRussel J Reiter
Jan 27, 2005·Journal of Psychopharmacology·Ulrich MüllerPeter Bublak
Apr 16, 2004·Blood Pressure·Andreas ZellerEdouard Battegay
Jun 5, 2019·The European Journal of Neuroscience·Horst SchicknickWolfgang Tischmeyer
Jul 19, 2017·Journal of Clinical Psychopharmacology·Shuhua DengChang Qiu
Jan 22, 2003·The Cochrane Database of Systematic Reviews·N J CrosbyC E Clarke
Mar 2, 2021·Frontiers in Cardiovascular Medicine·Fedor Simko, Tomas Baka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

© 2021 Meta ULC. All rights reserved